Location: Home
  • search
  • go
  • Relate News
  • 4/23/2019CNIPA Releases Draft Amendments to the Guidelines for Patent Examinati...
  • 4/23/2019Caixin's In-Depth Look at China's Health Insurance Dilemma and Transfo...
  • 4/23/2019Houston Cancer Center Fires Three Chinese Scientists
  • 4/23/2019Hua Medicine Initiates First Combination Study of Dorzagliatin with SG...
  • 4/23/2019China's Legislature Begins Second Review of the Proposed Vaccine Manag...
  • 4/23/2019Boehringer Ingelheim Increases Focus on Chinese Rural Areas
  • 4/22/2019Lilly Announces Sale of Legacy Antibiotics Brands and Manufacturing Fa...
  • 4/22/2019Amendment of Drug Administration Law and Draft Vaccine Management Law ...
  • 4/22/2019China to Amend Healthcare Laws Relating to Physicians
  • 4/19/2019NMPA Solicits Comments on Draft Announcement for Nature Determination ...
  • 4/19/2019Recent Executive Moves
  • 4/18/2019Rare Diseases in China, Their High Treatment Costs, and the People Pub...
  • 4/18/2019I-Mab Signs Agreement with Roche for Clinical Research of TJD5 in Comb...
  • 4/18/2019HitGen Achieves Milestone from DEL Discovery Alliance with Merck &...
  • 4/18/2019U.S. Senators Propose Bill to Sanction Chinese Pharmchem Cos over Fent...
  • 4/18/2019Lonza's Specialty API Business Disrupted by Chinese Plant Explosion
  • 4/17/2019Rexahn Pharma, BioSense Global Announce License Agreement for Anticanc...
  • 4/17/2019CASI In-Licenses Exclusive Worldwide Rights to Novel Anti-CD38 mAb Pro...
  • 4/17/2019GSK CEO Pledges to Learn from Mistakes in the Booming Chinese Vaccine ...
  • 4/17/2019Pharmaceutical Antitrust in China
  • 4/17/2019NMPA Issues the Chinese Edition of ICH Guideline M4 Documents
  • 4/17/2019NHSA Issues the Action Plan for 2019 National Reimbursement Drug List ...
  • 4/17/2019NHC Pledges More Efforts to Address Medicine Shortage
  • 4/16/2019I-Mab Bio and WuXi Bio Announce Long-term Strategic Manufacturing Part...
  • 4/16/2019Tianjin Tanabe and Servier China Enter Strategic Co-promotion Deal for...
  • 4/16/2019NHC Publishes Report on Status Quo of Chinese Antibiotic Management an...
  • 4/16/2019MSK-CTONG Collaboration Will Accelerate US-China Clinical Trials
  • 4/16/2019GSK-Pfizer Consumer Healthcare JV to Focus on the U.S. and China Marke...
  • 4/16/2019CStone Gains Chinese IND Approval for Avapritinib Phase I/II Bridging ...
  • 4/16/2019LSK BioPharma and Hengrui Medicine Announce FDA Clearance to Initiate ...
  • Page:230/720 Total number of articles:21572: [First][<<] [228] [229] [230] [231] [232] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group